Back to results
Not yet recruitingPhase 3

Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes

NCT07527078

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Gan & Lee Pharmaceuticals

Beijing, China

View on ClinicalTrials.gov
Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes — TrialFind